Mitral E Wave Deceleration Time to Peak E Velocity Ratio and Cardiovascular Outcome in Hypertensive Patients During Antihypertensive Treatment (from the LIFE Echo-Substudy)
October 3rd, 2009 Posted by: admin
Publication year: 2009<br><b>Source:</b> The American Journal of Cardiology, Volume 104, Issue 8, 15 October 2009, Pages 1098-1104<br>Marcello, Chinali , Gerard P., Aurigemma , Giovanni, de Simone , Rakesh K., Mishra , Eva, Gerdts , …<br><br>The early mitral flow deceleration time (DTE) is a prognostically validated marker of left ventricular diastolic dysfunction. It has been reported that the DTE is influenced by the loading conditions, which can vary during antihypertensive treatment. We hypothesized that normalization of the DTE for mitral peak E-velocity (mitral deceleration index [MDI]) might better predict incident cardiovascular (CV) events in hypertensive patients during treatment compared to DT
